The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 19, 2021

Filed:

Dec. 23, 2016
Applicant:

Themis Bioscience Gmbh, Vienna, AT;

Inventors:

Matthias Müllner, Pixendorf, AT;

Erich Tauber, Muckendorf, AT;

Patrick Csar, Königstetten, AT;

Angelika Irmler, Vienna, AT;

Katrin Ramsauer, Vienna, AT;

Sabrina Schrauf, Mörbisch am See, AT;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01D 15/38 (2006.01); C12N 7/00 (2006.01); A61K 39/12 (2006.01); C12N 15/86 (2006.01); A61K 39/165 (2006.01); B01J 20/282 (2006.01); C12N 7/02 (2006.01); A61P 31/14 (2006.01); B01D 15/36 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 39/165 (2013.01); A61P 31/14 (2018.01); B01D 15/3804 (2013.01); B01J 20/282 (2013.01); C12N 7/00 (2013.01); C12N 7/02 (2013.01); C12N 15/86 (2013.01); B01D 15/361 (2013.01); C12N 2760/00034 (2013.01); C12N 2760/00051 (2013.01); C12N 2760/18051 (2013.01); C12N 2760/18434 (2013.01); C12N 2760/18443 (2013.01); C12N 2770/24121 (2013.01); C12N 2770/24122 (2013.01); C12N 2770/24134 (2013.01); C12N 2770/24151 (2013.01); C12N 2800/22 (2013.01); C12N 2840/105 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present invention provides purification strategies for sterically demanding, i.e. large and pleomorphic, infectious virus particles or VLPs derived therefrom, preferably having a measles virus scaffold to yield fractions or compositions with a significantly reduced content of contaminating host cell DNA and a reduced content of further process-related impurities. Further provided are methods of propagating and purifying infectious virus particles having a measles virus scaffold suitable to provide a preparation having a strongly reduced content of contaminating host cell DNA and a reduced content of further process-related impurities for immunogenic or anti-tumor purposes. In addition, immunogenic and vaccine compositions based on the above methods are provided. Finally, there are provided immunogenic or vaccine compositions produced by the disclosed methods, which are suitable for use in immunogenic or prophylactic vaccination treatment of a subject in need thereof.


Find Patent Forward Citations

Loading…